Cash & Equivalents
CVS Health Cash & Equivalents decreased by 9.6% to $8.45B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 1.5%, from $8.59B to $8.45B. Over 5 years (FY 2020 to FY 2025), Cash & Equivalents shows relatively stable performance with a 1.5% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase signals improved liquidity and financial flexibility, while a decrease may indicate heavy capital expenditure, debt repayment, or aggressive share buybacks.
Detailed definition
Represents the most liquid assets on the balance sheet, including physical currency and short-term investments with matu...
Peer comparison
Large-cap technology peers often maintain high cash balances to fund rapid innovation and offset the cyclical nature of consumer electronics.
cash_and_equivalentsHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $7.34B | $10.04B | $9.41B | $11.61B | $12.46B | $17.56B | $12.95B | $14.96B | $14.13B | $13.38B | $8.20B | $10.11B | $12.82B | $7.14B | $8.59B | $10.35B | $12.03B | $9.35B | $8.45B |
| QoQ Change | — | +36.9% | -6.3% | +23.4% | +7.3% | +40.9% | -26.3% | +15.5% | -5.5% | -5.3% | -38.7% | +23.3% | +26.8% | -44.3% | +20.3% | +20.5% | +16.2% | -22.2% | -9.6% |
| YoY Change | — | — | — | — | +69.9% | +74.9% | +37.6% | +28.8% | +13.4% | -23.8% | -36.7% | -32.4% | -9.3% | -46.6% | +4.8% | +2.4% | -6.2% | +31.0% | -1.5% |
Cash & Equivalents at Other Companies
Frequently Asked Questions
- What is CVS Health's cash & equivalents?
- CVS Health (CVS) reported cash & equivalents of $8.45B in Q4 2025.
- How has CVS Health's cash & equivalents changed year-over-year?
- CVS Health's cash & equivalents decreased by 1.5% year-over-year, from $8.59B to $8.45B.
- What is the long-term trend for CVS Health's cash & equivalents?
- Over 5 years (2020 to 2025), CVS Health's cash & equivalents has grown at a 1.5% compound annual growth rate (CAGR), from $7.85B to $8.45B.
- What does cash & equivalents mean?
- Money in the bank and very short-term investments that can be turned into cash almost instantly.